FCPA: The Critical Issues Facing the Medical Device and Pharmaceuticals Industries
Richard Smith, Partner, Fulbright & Jaworski; John Kelly, Senior Counsel, Fulbright & Jaworski; Elliott Leary, KPMG Forensic Partner; Phil Desing, KPMG Forensic Managing Director
| March 11, 2010 | 2:00pm ET
Healthcare & Pharmaceutical Institute
This Webcast from KPMG Forensic and Fulbright & Jaworski addresses several issues facing the medical device and pharmaceuticals industries related to the Foreign Corrupt Practices Act (FCPA).
The Webcast addresses why it is essential to understand the FCPA and discusses how the FCPA impacts the medical device and pharmaceuticals industries.
The discussion also covers recent investigations and enforcement actions as well as FCPA risk and mitigation strategies.